Firefly Neuroscience Inc (AIFF)

$0.83 -0.03 (-3.00%)
Market Cap 11.81M
Revenue (ttm) 110,000.00
Net Income (ttm) -10.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,509.09%
Debt to Equity Ratio 0.00
Volume 56,600
Avg Vol 140,116
Day's Range N/A - N/A
Shares Out 13.49M
Stochastic %K 3%
Beta 1.85
Analysts Strong Buy
Price Target N/A

Company Profile

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serv...

Industry: Software - Application
Sector: Technology
Phone: 888 237 6412
Address:
1100 Military Road, Kenmore, United States
SJDodge
SJDodge Feb. 3 at 10:57 PM
$AIFF - WPC is finished and Warrant inducement is confirmed 90% complete (721k/800k) according to latest OS. Only thing left is for MM's to shake remaining weak hands... will double my position tomorrow!
1 · Reply
Trinity031983
Trinity031983 Feb. 3 at 5:03 PM
$AIFF Potential Catalysts (Current Outlook): With no fresh news flow in 2026 so far, potential upside depends on upcoming execution: 1. Q4/Full-Year 2025 Earnings (Expected Late Feb/Early March 2026): Could showcase revenue momentum from BNA™ commercialization, Evoke synergies, higher scan volumes, or cash improvements—often a key trigger for micro-cap volatility. 2. Clinical/Research Milestones: Updates from ongoing studies (e.g., Heidelberg genetic research, vascular dementia trials, biomarker work) or new publications could generate interest. 3. Partnership/Commercial Traction: Expansions via Nvidia tools, clinic integrations, or new deals in neurotech/mental health. 4. Sector Tailwinds: Broader AI/biotech/neuro interest (e.g., precision medicine) benefiting FDA-cleared platforms like BNA™.
0 · Reply
ItisTimeForUtility
ItisTimeForUtility Jan. 28 at 6:13 PM
$AIFF Is it time to open a position in AIFF? I have a bid on at .85, if someone wants to throw in the towel.
0 · Reply
resistancebreakers
resistancebreakers Jan. 22 at 9:48 PM
$AIFF
0 · Reply
QuantumTechnology
QuantumTechnology Jan. 13 at 5:40 PM
$AIFF On my watchlist, aiming to buy at 0.80$.
0 · Reply
resistancebreakers
resistancebreakers Jan. 13 at 1:18 PM
$AIFF
0 · Reply
Classic1
Classic1 Jan. 9 at 8:44 AM
$AIFF why am I thinking more aiff and more pydn????
1 · Reply
QuantumTechnology
QuantumTechnology Jan. 8 at 9:59 PM
Called you $AIFF for 28% profits! Make sure to FOLLOW me.
0 · Reply
QuantumTechnology
QuantumTechnology Jan. 6 at 11:55 AM
$AIFF Nice profits! Follow me for more!
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jan. 6 at 5:15 AM
$AIFF As alerted we banked nicely and may not be done🥊🥊
0 · Reply
Latest News on AIFF
Firefly Neuroscience Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 7:45 AM EST - 2 months ago

Firefly Neuroscience Reports Third Quarter 2025 Financial Results

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Sep 5, 2025, 7:55 AM EDT - 5 months ago

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Aug 26, 2025, 7:45 AM EDT - 5 months ago

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Jul 14, 2025, 7:45 AM EDT - 7 months ago

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Neuroscience to be Added to the Russell Microcap® Index

Jun 23, 2025, 8:05 AM EDT - 8 months ago

Firefly Neuroscience to be Added to the Russell Microcap® Index

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Jun 20, 2025, 7:45 AM EDT - 8 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 9:00 PM EDT - 9 months ago

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 7:45 AM EDT - 9 months ago

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Mar 6, 2025, 7:30 AM EST - 11 months ago

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 21, 2025, 8:00 AM EST - 1 year ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 11, 2025, 7:45 AM EST - 1 year ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Feb 7, 2025, 7:30 AM EST - 1 year ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Jan 14, 2025, 12:25 PM EST - 1 year ago

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Jan 14, 2025, 7:45 AM EST - 1 year ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Dec 31, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 14, 2024, 5:30 PM EST - 1 year ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Nov 6, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 25, 2024, 4:10 PM EDT - 1 year ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 16, 2024, 9:20 AM EDT - 1 year ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Sep 10, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 26, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 21, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

Aug 13, 2024, 4:06 PM EDT - 1 year ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

SJDodge
SJDodge Feb. 3 at 10:57 PM
$AIFF - WPC is finished and Warrant inducement is confirmed 90% complete (721k/800k) according to latest OS. Only thing left is for MM's to shake remaining weak hands... will double my position tomorrow!
1 · Reply
Trinity031983
Trinity031983 Feb. 3 at 5:03 PM
$AIFF Potential Catalysts (Current Outlook): With no fresh news flow in 2026 so far, potential upside depends on upcoming execution: 1. Q4/Full-Year 2025 Earnings (Expected Late Feb/Early March 2026): Could showcase revenue momentum from BNA™ commercialization, Evoke synergies, higher scan volumes, or cash improvements—often a key trigger for micro-cap volatility. 2. Clinical/Research Milestones: Updates from ongoing studies (e.g., Heidelberg genetic research, vascular dementia trials, biomarker work) or new publications could generate interest. 3. Partnership/Commercial Traction: Expansions via Nvidia tools, clinic integrations, or new deals in neurotech/mental health. 4. Sector Tailwinds: Broader AI/biotech/neuro interest (e.g., precision medicine) benefiting FDA-cleared platforms like BNA™.
0 · Reply
ItisTimeForUtility
ItisTimeForUtility Jan. 28 at 6:13 PM
$AIFF Is it time to open a position in AIFF? I have a bid on at .85, if someone wants to throw in the towel.
0 · Reply
resistancebreakers
resistancebreakers Jan. 22 at 9:48 PM
$AIFF
0 · Reply
QuantumTechnology
QuantumTechnology Jan. 13 at 5:40 PM
$AIFF On my watchlist, aiming to buy at 0.80$.
0 · Reply
resistancebreakers
resistancebreakers Jan. 13 at 1:18 PM
$AIFF
0 · Reply
Classic1
Classic1 Jan. 9 at 8:44 AM
$AIFF why am I thinking more aiff and more pydn????
1 · Reply
QuantumTechnology
QuantumTechnology Jan. 8 at 9:59 PM
Called you $AIFF for 28% profits! Make sure to FOLLOW me.
0 · Reply
QuantumTechnology
QuantumTechnology Jan. 6 at 11:55 AM
$AIFF Nice profits! Follow me for more!
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jan. 6 at 5:15 AM
$AIFF As alerted we banked nicely and may not be done🥊🥊
0 · Reply
QuantumTechnology
QuantumTechnology Jan. 5 at 9:15 PM
$AIFF Follow me on Stocktwits!
1 · Reply
ItisTimeForUtility
ItisTimeForUtility Jan. 5 at 3:59 PM
$AIFF Printing 1.02- the blind squirrel got an acorn!
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jan. 5 at 2:45 PM
$AIFF We're green.. Where's the $1.00??🚨
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 1 at 9:20 AM
$AIFF
0 · Reply
SJDodge
SJDodge Dec. 31 at 8:48 PM
$AIFF .85-.86 seems to be the new structural floor...
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Dec. 31 at 8:55 AM
$AIFF Finally after a beat down.. Looks to bounce back over $1.00 imo🚨🚨
0 · Reply
SJDodge
SJDodge Dec. 30 at 10:56 PM
$AIFF
1 · Reply
SJDodge
SJDodge Dec. 30 at 8:36 PM
$AIFF - Seems WPC completed their position exit, warrant exchange/forced exercise completed today, today was the capitulation day ... new floor has formed around .88-90. Let's get some 8k's so we can start the recovery ...
0 · Reply
Snookville
Snookville Dec. 30 at 5:27 PM
$AIFF sheesh
0 · Reply
BenchmarkBolt
BenchmarkBolt Dec. 27 at 3:44 PM
$AIFF Market participants want evidence that strategy converts to numbers; customer retention trends will be critical to monitor — discipline in guidance could rebuild trust. Only demonstrated reliability will sustain upside potential.
1 · Reply
FiscalSignalCraft
FiscalSignalCraft Dec. 27 at 8:40 AM
$AIFF Risk tolerance remains selective and tied closely to execution credibility. Operational cadence needs to tighten meaningfully. Evidence of repeatability could meaningfully alter perception. Ultimately, disciplined delivery will shape the outcome.
0 · Reply
CoolReally
CoolReally Dec. 26 at 9:49 PM
$AIFF remember, the only remaining communication from management will be the announcement of their R/S or dilution. EXTREMELY BEARISH. Stay away or get out now!
1 · Reply